Center for Human Reproduction Receives Two New Patent Approvals on Androgen Supplementation for Women with Diminished Ovarian Reserve (DOR) Attempting to Conceive (amazon) (shopzilla)


New York, NY (PRWEB) August 14, 2013

Center for Human Reproduction (CHR), a leading fertility research and treatment center in New York City, announced approval of two patent applications regarding the therapeutic benefits and mechanisms of androgen supplementation for pregnancy chances of women with diminished ovarian reserve (DOR).

Combined, the two newly awarded patents (#8,501,718 and #8,501,719) describe the use of supplementation with androgens, such as dehydroepiandrosterone (DHEA), to restore ovarian environments deteriorated due to advanced female age (over 38 years) or premature ovarian aging (indicated by abnormally high FSH or abnormally low AMH levels for age).

The new patents follow the two previously awarded patents (#7,615,544 and #8,067,400), which describe DHEA supplementation as a means to improve various quality parameters of eggs and embryos, to shorten time to pregnancy and to improve pregnancy rates. Improving pregnancy chances for women with DOR has been a long-standing research focus at CHR, and CHRs introduction of DHEA supplementation, almost a decade ago, truly revolutionized fertility treatments for women with DOR.

Having now discovered the mechanisms by which supplementation with DHEA or other androgens achieves all of these effects, one of the new patents (#8,501,719) describes these improvements as stemming from restoration of the ovarian environment to its youthful state with healthy androgen levels. The other (#8,501,718) identifies improvements in anti-M

Related Blogs

    Relivs LunaRich Earns Ingredient Patent (amazon) (shopzilla)


    Chesterfield, MO (PRWEB) August 08, 2013

    Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich

    Related Blogs

      Healthy Energy Shot 24K Becomes Ninth Reliv Product to Earn Patent (amazon) (shopzilla)


      Chesterfield, MO (PRWEB) July 26, 2013

      Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, this week announced that healthy energy shot 24K has earned a patent from the US government. Dr. Carl W. Hastings, Relivs chief scientific officer and creator of 24K, made the announcement as part of opening night at Relivs 25th Anniversary International Conference.

      This patent validates the work our R&D team put into making 24K unlike any other energy product on the market, Hastings said. 24K provides a healthy alternative to the high-caffeine, high-sugar energy shots that have become so prevalent in recent years. And with 24K, you not only get energy, but nutritional support for mental focus and stress relief as well.

      The patent for 24K comes two years after the product was first introduced and was named the Peoples Choice for Favorite New Consumer Product by the American Business Awards.

      Cracking the Fatigue Cycle

      Energy drinks have surged in popularity in recent years, and health advocates have expressed concern about the excessive amounts of caffeine found in most of these products. The U.S. Food and Drug Administration continues to investigate reports of illness, injury and even death of people who drank products marketed as energy drinks or energy shots. In June, the American Medical Association adopted a policy supporting a ban of the marketing of high stimulant/caffeine drinks to adolescents under the age of 18.

      Most popular energy products rely on caffeine and sugar to provide a quick jolt, Hastings said. But this can cause an unhealthy spike in heart rate and blood sugar, leading to an inevitable crash. Such stimulants only mask the symptoms of fatigue. 24K provides a healthy solution by addressing the underlying problem the fatigue cycle.

      Physical fatigue and mental fog go hand-in-hand, and stress is a leading contributor to both. Together, they make up the fatigue cycle. 24K delivers 24 active ingredients backed by clinical research to address all three factors. View healthy energy shot 24K’s ingredient list.

      24K becomes the ninth Reliv nutritional formula to earn a US patent, joining Reliv Classic

      Related Blogs

        Subscribe By Email for Weekly Updates.